Skip to main content

The synthesis of TNF-alpha conjugates with alendronic acid

Russian Journal of Bioorganic Chemistry volume 42, pages 638–645 (2016)Cite this article

Abstract

Conjugates of recombinant human tumor necrosis factor alpha (TNFα) and alendronic acid linked through the protein sulfhydryl, carboxyl, and amino groups were obtained with crosslinking agents of different types. The conjugation reactions were conducted in solution and on a solid phase. Unlike the conjugation reactions in solution, the method involving immobilization of active components on a hydroxyapatite column was shown to result in the conjugates with a specified stoichiometry and a high degree of homogeneity. The TNFα conjugates retained the specific cytolytic activity and demonstrated the higher affinity to hydroxyapatite, an analogue of the bone mineral matrix, than TNFα.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Abbreviations

ALN:

alendronic acid

EDC:

1-ethyl-3-[3-dimethylaminopropyl]carbodiimide

GLT:

glutaric aldehyde

HAP:

hydroxyapatite

Sulfo-SMCC:

sulfosuccinimidyl-4-(Nmaleimidomethyl) cyclohexane-1-carboxylate

TNFα:

tumor necrosis factor

References

  1. Coleman, R.E., Semin. Oncol., 2007, vol. 34, no. Suppl. 4, pp. 11–S16.

    Article  Google Scholar 

  2. Ketlinskii, S.A. and Simbirtsev, A.S., Tsitokiny (Cytokines), Moscow: Foliant, 2008.

    Google Scholar 

  3. Shmelev, V.A., Interferon-gamma, faktor nekroza opukholei, timozin-al’fa1–protivoinfektsionnye i protivoopukholevye tsitokiny i preparaty (Interferon gamma, Tumor Necrosis Factor, Thymosin alpha-1—Antiinfective and Anticancer Drugs and Cytokines), Moscow: Medpraktika, 2008.

    Google Scholar 

  4. Nasonov, E.L., Skripnikova, I.A., and Nasonova, V.A., Problema osteoporoza v revmatologii (Problem of Osteoporosis in Rheumatology), Moscow: Stin, 1997.

    Google Scholar 

  5. Ishizuka, S., Kurihara, N., Hiruma, Y., Miura, D., Namekawa, J., Tamura, A., Kato-Nakamura, Y., Nakano, Y., Takenouchi, K., Hashimoto, Y., Nagasawa, K., and Roodman, G.D., J. Steroid Biochem. Mol. Biol., 2008, vol. 110, nos. 3–5, pp. 269–277.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  6. Frith, J.C., Mönkkönen, J., Blackburn, G.M., Russell, R.G., and Rogers, M.J., J. Bone Miner. Res., 1997, vol. 12, pp. 1358–1367.

    CAS  Article  PubMed  Google Scholar 

  7. Danilenko, E.D. and Belkina, A.O, Biofarm. Zh., 2014, vol. 6, no. 6, pp. 44–53.

    Google Scholar 

  8. Knorre, D.G. and Myzina, S.D., Biologicheskaya khimiya: Ucheb. dlya khim., biol. i med. spets. vuzov (Biological Chemistry: Textbook for Chemical, Biological, and Medical Specialities of Universities), Moscow: Vyssh. shkola, 2000.

    Google Scholar 

  9. Uludag, H., Kousinioris, N., Gao, T., and Kantoci, D, Biotechnol. Prog., 2000, vol. 16, pp. 258–267.

    CAS  Article  PubMed  Google Scholar 

  10. Uludag, H. and Yang, J, Biotechnol. Prog., 2002, vol. 18, no. 3, pp. 604–611.

    CAS  Article  PubMed  Google Scholar 

  11. Ehrick, R.S., Capaccio, M., Puleo, D.A., and Bachas, L.G, Bioconjug. Chem., 2008, vol. 19, pp. 315–321.

    CAS  Article  PubMed  Google Scholar 

  12. Pustoshilova, N.M., Kileva, E.V., Denisova, L.Ya., Shingareva, N.V., Korobko, V.G., Denisov, L.A., Masycheva, V.I., Sandakhchiev, L.S., and Kalinin, Yu.T., RF Patent No. 2144958, 1997.

    Google Scholar 

  13. Lebedev, L.R., Zernov, Yu.P., Andreeva, I.S., and Pustoshilova, N.M, Biotekhnologiya, 1995, no. 12, pp. 19–24.

    Google Scholar 

  14. Scopes, R., Metody ochistki belkov (Protein Purification Methods), Moscow: Mir, 1985.

    Google Scholar 

  15. Solov’eva, G.A., et al., Praktikum po biokhimii (A Practical Course in Biochemistry), Severin, S.E. and Solov’eva, G.A., Eds., Moscow: Izd. Mosk. Univ., 1989.

  16. Laemmli, U.K, Nature, 1970, vol. 227, pp. 680–685.

    CAS  Article  PubMed  Google Scholar 

  17. Meager, A., Leung, H., and Woolley, J., J. Immunol. Methods, 1989, vol. 116, pp. 1–17.

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Medical Biotechnology, FBRI SRC VB “Vector,”, Berdsk, Novosibirsk oblast, 633010, Russia

    E. A. Volosnikova, I. F. Demin, G. M. Levagina, L. R. Lebedev, A. I. Zakabunin & E. D. Danilenko

  2. Institute of Chemical Biology and Fundamental Medicine, Siberian Branch, Russian Academy of Sciences, Novosibirsk, 630090, Russia

    A. I. Zakabunin

Authors
  1. E. A. Volosnikova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. F. Demin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. M. Levagina
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. R. Lebedev
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. I. Zakabunin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. D. Danilenko
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. A. Volosnikova.

Additional information

Original Russian Text © E.A. Volosnikova, I.F. Demin, G.M. Levagina, L.R. Lebedev, A.I. Zakabunin, E.D. Danilenko, 2016, published in Bioorganicheskaya Khimiya, 2016, Vol. 42, No. 6, pp. 704–711.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Volosnikova, E.A., Demin, I.F., Levagina, G.M. et al. The synthesis of TNF-alpha conjugates with alendronic acid. Russ J Bioorg Chem 42, 638–645 (2016). https://doi.org/10.1134/S1068162016060145

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1068162016060145

Keywords

  • alendronic acid
  • binding to hydroxyapatite
  • conjugation
  • tumor necrosis factor alpha recombinant human